Loading clinical trials...
Loading clinical trials...
A Phase 3, Randomized, Double-blinded, Placebo-controlled, Multicenter, Efficacy and Safety Study of Four Weeks of Treatment With Imiquimod Creams for Actinic Keratoses
Conditions
Interventions
imiquimod cream
imiquimod cream
+1 more
Locations
26
United States
Fremont, California, United States
Los Angeles, California, United States
Riverside, California, United States
San Diego, California, United States
Vallejo, California, United States
Miami, Florida, United States
Start Date
January 1, 2008
Primary Completion Date
July 1, 2008
Completion Date
July 1, 2008
Last Updated
June 29, 2010
NCT06385340
NCT06321003
NCT06499415
NCT03906253
NCT05987553
NCT05923060
Lead Sponsor
Graceway Pharmaceuticals, LLC
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions